Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protox Therapeutics retains CTBR for preclinical testing of PSA-PA1

Aug. 23, 2004

Viventia Biotech and Acceptys enter option agreement for anticancer antibodies

Aug. 23, 2004

Taxotere approved for early-stage breast cancer

Aug. 23, 2004

New phase I/II study of CG-7870 plus Taxotere for prostate cancer

Aug. 23, 2004

New EGFR inhibitors identified by Ariad scientists

Aug. 23, 2004

Fast track status for temsirolimus for first-line treatment of advanced RCC

Aug. 19, 2004

MediGene acquires anticancer drugs and technology of Munich Biotech

Aug. 19, 2004

Abbott presents new Bcl-targeting agents with potential in cancer chemotherapy

Aug. 18, 2004

FDA and Genentech issue warning on Avastin

Aug. 18, 2004

New HSP90 inhibitors and their use in cancer and other disorders

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...